Camurus receives EthiFinance ESG Platinum Medal

Camurus is pleased to announce that the company has been awarded the EthiFinance ESG Platinum Medal. The award, granted by the independent European ESG rating company EthiFinance, underscores Camurus' steadfast commitment to sustainability and the progress of the company’s systematic sustainability work and performance.

“We are honored to be awarded the ESG Platinum Medal by EthiFinance. It is a great recognition of our dedicated efforts to create value and make a positive difference for patients, caregivers, and society, alongside our work to minimize sustainability-related risks and environmental impact throughout our value chain”, says Iris Rehnström, Director Sustainability at Camurus.

The industry comparison, commissioned and funded by investors, encompassed 86 companies within the biotechnology and pharmaceutical sectors. The assessment, conducted in 2024 with data reported for 2023, focused on material aspects of the industry within environmental, social, governance, and external stakeholder engagement. In the assessment, Camurus received a score of 83/100 – the second highest within the group.

For further information see EthiFinance’s report: https://www.ethifinance.com/publications/2024-corporate-sustainability-performance-in-the-biotechnologies-pharmaceutical-sector/

For more information about Camurus’ sustainability work see: https://www.camurus.com/sustainability/

About Camurus
Camurus is an international, science-led biopharmaceutical company committed to developing and commercializing innovative, long-acting medicines for improving the lives of patients with severe and chronic diseases. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal^® technology and its extensive R&D expertise. The R&D pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases. Camurus has operations across Europe, the US, and Australia, with headquarters in Lund, Sweden. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit www.camurus.com and LinkedIn.